The journal does not have article processing charges, neither article submission charges.
All prepared manuscripts should be submitted to the following E-mail address: firstname.lastname@example.org
Download Acta Biologica Marisiensis manuscript template
Cover letter and open access license
All manuscripts should be submitted together with a cover letter and an open access license attached as separate files.
Download Acta Biologica Marisiensis cover letter template
Download Acta Biologica Marisiensis open access license template
Acta Biologica Marisiensis do not support pushing important results and information into supplementary sections. However, data that are not of primary importance to the text, or which cannot be included in the article because it is too large can be sent via E-mail (email@example.com) and will be displayed online along with the published article.
The Supplementary material can be sent in Microsoft Office Word 97-2003 Document. Supplementary material is not typeset so please ensure that all information is clearly presented, the appropriate caption is included in the file and not in the manuscript, and that the style conforms to the rest of the article.
Authorship and authors responsibilities
The Journal Acta Biologica Marisiensis follows the International Committee of Medical Journal Editors guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work;
- Drafting the work or revising it critically for important intellectual content;
- Provide approval for publication of the content;
- Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributors, who do not meet these criteria, but nonetheless provided important contributions to the final manuscript, should be included in the acknowledgements section.
The corresponding author takes primary responsibility for communication with the journal and editorial board during the submission process, throughout peer review and during publication. The corresponding author is also responsible for ensuring that the submission adheres to all journal requirements. The corresponding author should also be available post-publication to respond to any queries or critiques.
All research studies involving human subjects must have received approval of the appropriate institutional ethics committee and informed consent must be obtained from all the patients participating in the studies, prior to manuscript submission.
In cases where the institutional ethics review committee ruled that approval from them was not required or that the need for informed consent was unnecessary, a statement from the committee to this end should be forwarded to the Editor with the manuscript.
Human and animal rights
Studies involving experimental research on animals or humans must conform to the guiding principles of the Declaration of Helsinki. In order to respect a patient`s right to privacy, identifying information such as patients` names, images, initials of hospital numbers should not be included in any published material (tables, figures, text), unless the information is essential for scientific content. In these cases written permission must be obtained from the patient, and should be submitted to the editorial office at the time of manuscript submission. In the case of animal experiments, both national and the institutional guidelines pertaining to the experimental use of laboratory animals should be rigidly followed.
In case of manuscripts presenting clinical trials, the clinical trial should be registered in a public trials registry at or before the time of first patient enrollment, as a condition for consideration for publication. Trials should be preferably registered in ClinicalTrials.gov, but any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) is acceptable, in accordance with the guidelines of the International Committee of Medical Journal Editors.
Conflict of interest (Declaration of Interests)
The manuscript should contain a statement fully disclosing any conflict of interest related to the manuscript. If there are no conflicts of interest, this should be stated as “none declared”. Material and financial support should also be acknowledged.
Scientific misconduct includes data fabrication, falsification, plagiarism, redundant publication, ghost authorship or other fraudulent research practices. In order to prevent plagiarism issues, all manuscripts sent to the journal will be screened using anti-plagiarism soft-ware. Where there is a suspicion of scientific misconduct, the Editor will act in conformity with the principles stated in the COPE guidelines and if the fraudulent practice is confirmed the manuscript will be rejected outright and without the Editor entering into any further correspondence.